Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future

doi:10.4254/wjh.v8.i1.58

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8103)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

597

WORD

350

HTML

3193

Tables (1-5)

177

Sum=4317

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

403

Download

510

Sum=913

Publishing Process of This Article

Item

Count

Browse

1055

Download

1818

Sum=2873

Jan 8, 2016 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Jan 8, 2016; 8(1): 58-68
Published online Jan 8, 2016. doi: 10.4254/wjh.v8.i1.58

Table 3 Selection criteria based on functional/radiological features of the tumor

Ref.	Parameters	Importance
Hiraoka et al[56]	Hyperintensity on gadoxetic acid-enhanced MRI	HCC with more malignant potential
Ferda et al[12]	Hipervascularity or hiperaccumulation of (18)FDG/PET/with Dual-phase CT angiography (arterial/portal phase)	Distinguishing between welland
Ferda et al[12]		Poorly differentiated HCC
Ochi et al[57]	High positivity in (18)FDG/PET/CT	Increase the risk of early recurrence
Kornberg et al[58]	mSUV	Reflects the existence of distant microsatellite
Kornberg[59]	Positivity in (18)FDG/PET/CT	Statistically significant lower survival post LT

CT: Computerized tomography; MRI: Magnetic resonance imaging; HCC: Hepatocellular carcinoma; PET: Positron emission tomography; LT: Liver transplantation; mSUV: Maximun standized uptake value; (18)FDG: (18)F-fluorodeoxyglucose.

Citation: Soriano A, Varona A, Gianchandani R, Moneva ME, Arranz J, Gonzalez A, Barrera M. Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World J Hepatol 2016; 8(1): 58-68
URL: https://www.wjgnet.com/1948-5182/full/v8/i1/58.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i1.58